Connect with us

Crypto World

Ethena taps FalconX for institutional stablecoin lending

Published

on

Morpho rolls out Midnight for fixed term lending on Base

Ethena has appointed FalconX as an institutional lending partner, adding an overcollateralized stablecoin credit facility to the assets backing its synthetic dollar business.

Summary

  • Ethena will provide a revolving senior secured credit facility through a FalconX lending vehicle.
  • FalconX will use the capital to acquire crypto-backed institutional loan receivables.
  • Ethena will hold a first-priority security interest over the vehicle’s assets.
  • Commercial thresholds, portfolio limits, pricing terms, and the facility’s size remain confidential.

Ethena said in an Aug. 14 announcement that the agreement will place stablecoins into overcollateralized lending arrangements managed through digital asset prime broker FalconX.

Under the transaction, FalconX can use Ethena’s capital to expand lending activity on its balance sheet. Ethena, in turn, expects to receive terms supported by FalconX’s loan-origination and secured-lending operations.

The protocol described the expected terms as more attractive on a risk-adjusted basis than other available channels. Neither party disclosed the amount committed, the expected return, the loan duration, or the assets eligible as collateral in the initial announcement.

Advertisement

How the Ethena-FalconX lending facility works

Rather than issuing a standard bilateral loan directly to FalconX, Ethena will provide warehouse financing through a dedicated lending structure.

According to an Aug. 4 legal review from LlamaRisk, Ethena will serve as lead lender on a revolving senior secured credit facility extended to FalconX International Lending Opportunities SPC. The Cayman Islands company will act for FalconX International Lending Opportunities SP 1, a segregated portfolio designed as a bankruptcy-remote vehicle within the FalconX group.

Using the facility’s proceeds, the vehicle can acquire crypto-backed institutional loan receivables from two FalconX originators. The receivables and the vehicle’s other assets will then be pledged to Ethena as collateral.

LlamaRisk said Ethena will receive a first-priority security interest over all assets held by the vehicle. Other debt at the vehicle will rank below Ethena’s claim, while special-purpose-entity and separateness covenants are intended to limit exposure to financial problems elsewhere in the FalconX group.

Advertisement

Daily reporting forms another part of the arrangement. The legal review said Ethena will receive loan-level information every business day and will be able to check the related collateral against the wallet addresses holding it.

Public documents do not identify the borrowers, the credit limit, collateral ratios, or pricing provisions. LlamaRisk said commercial thresholds, portfolio parameters, and individual contractual terms remain confidential.

Overcollateralization limits Ethena’s borrower exposure

Overcollateralization requires borrowers to pledge assets worth more than the stablecoins they receive. The buffer gives a lender room to liquidate collateral if its value falls toward the outstanding loan amount, although the structure cannot remove market, operational, or counterparty risk.

In its framework for reviewing institutional lending agreements, LlamaRisk said collateral terms represent the most important protection for USDe reserve assets. Its checks cover eligible collateral, valuation methods, minimum collateral ratios, margin procedures, custody arrangements, and liquidation rights.

Advertisement

The risk adviser also examines whether collateral includes illiquid tokens, private receivables, or assets with limited secondary-market depth. Where another party can reuse or pledge the collateral elsewhere, the review considers whether Ethena retains a senior and enforceable claim.

LlamaRisk said liquidation rights should not depend on extended notice periods, court proceedings, or cooperation from a distressed borrower because rapid market moves could reduce the collateral buffer before a sale occurs.

FalconX describes its lending operation as offering customized institutional credit structures with different durations, collateral types, and notice periods. Its financing platform includes margin loans, over-the-counter lending, prime brokerage credit, and yield arrangements for institutional clients.

The companies already have an operating relationship. In September 2025, FalconX added support for USDe, allowing approved institutional clients to trade and hold the synthetic dollar, access OTC liquidity, and use it as collateral for credit or derivatives positions, crypto.news previously reported.

Advertisement

Institutional lending has become part of USDe backing

FalconX joins an institutional lending program that Ethena began building earlier in 2026. Governance records show that the protocol finalized its first agreements with Anchorage Digital, Maple Institutional, and Coinbase Asset Management during March and April.

Under Ethena’s structure, off-chain lending positions are included in its proof-of-reserves reporting and transparency dashboard. New lending counterparties also require separate review rather than gaining automatic access through an existing approval.

Institutional lending accounted for about $310 million, or 6.9%, of USDe backing on July 3, according to Ethena’s June governance report. The report placed the estimated annual percentage yield on that segment between 4% and 7%.

DeFi lending made up the largest share at roughly $2 billion, or 46%, across Aave, Morpho, Kamino, and Jupiter. Liquid stablecoins represented another 35%, while tokenized real-world assets accounted for 11.2%. Crypto basis positions, once central to Ethena’s model, had fallen to about $39 million, or 1% of the backing portfolio.

Advertisement

At the time of the report, Ethena recorded a backing ratio of 101.59% and a reserve fund of about $62 million. Its dashboard also showed around $1.2 billion in stablecoins available for redemptions, including USDtb, PYUSD, USDC, and USDT.

Institutional distribution has expanded alongside the changes to USDe’s reserves. In June, BlackRock integrated USDe with its Aladdin investment platform, while Ethena selected BlackRock’s BUIDL tokenized money market fund as the primary reserve asset for a white-label product.

Days earlier, StablecoinX reached Nasdaq following its merger with TLGY Acquisition Corp. The Ethena-focused company began trading under the ticker USDE with about 3.03 billion ENA tokens, valued at approximately $275 million using the 30-day average applied before closing.

U.S. rules depend on the FalconX entity involved

For U.S. institutions, the FalconX name covers several affiliated companies with different regulatory positions. The CFTC’s registered swap dealer list, current as of Jan. 15, includes FalconX Bravo Inc., which is also an approved member of the National Futures Association.

Advertisement

FalconX Delta operates as a trading platform for U.S. institutional clients and is registered with the Financial Crimes Enforcement Network as a money services business, according to the company’s licensing disclosures. State money-transmitter requirements also apply where listed by the company.

However, Ethena’s credit facility is being extended to a Cayman Islands segregated portfolio rather than FalconX Bravo or FalconX Delta. LlamaRisk’s review therefore examined the identity and jurisdiction of the contracting vehicle, the position of Ethena’s claim, the enforceability of its collateral rights, and the separation of the portfolio from other FalconX businesses.

The entity distinction follows earlier U.S. scrutiny of another FalconX affiliate. In May 2024, the CFTC settled charges against Falcon Labs, a Seychelles company, for acting as an unregistered futures commission merchant while giving U.S. customers access to digital asset derivatives platforms between October 2021 and March 2023.

The regulator ordered Falcon Labs to pay about $1.18 million in disgorgement and a $589,504 civil penalty. The CFTC said the reduced penalty accounted for the company’s cooperation and remedial work, including improved controls used to identify customer locations.

Advertisement

Source link

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Crypto World

Bitcoin (BTC), ether (ETH) prices hold steady while XMR, HYPE outperform

Published

on

Bitcoin (BTC), ether (ETH) prices hold steady while XMR, HYPE outperform

Bitcoin held near $63,600 after Wednesday’s in-line U.S. inflation print proved enough to calm nerves, but not enough to move markets decisively in either direction.

The largest cryptocurrency has added 0.30% since midnight UTC, while the broader crypto market capitalization dropped 0.54% over 24 hours to $2.18 trillion.

July CPI came in at 3.4% year over year, matching forecasts. Core inflation also eased, with the annual reading slipping to 2.5% from 2.6%. The producer price inflation figure due at 12:30 UTC may provide more impetus to a lackluster market.

As for U.S. equities, S&P 500 index futures gained 0.13% while Nasdaq 100 futures were little changed.

Advertisement

Derivatives positioning

  • Futures market churn continues: 24-hour volume stands at $147 billion, up 6% on the day, but cumulative open interest (OI) across all cryptocurrency futures has held flat near $116 billion.
  • XRP positioning stays elevated: XRP futures OI is perched at 2.67 billion tokens, the most since October, for a third straight day. The 24-hour cumulative volume delta (CVD) remains negative, pointing to bearish bets being executed at market prices more than bullish ones. These paint a bearish picture, flagging a possible drop below $1. There’s a silver lining, though: The annualized perpetual funding rate is near 8%, pointing to a bias toward bullish bets.
  • ADA and BCH show heavy bearish tilt: Both coins are seeing funding rates of -10% or lower, pointing to a clear investor preference for bearish positions. They both also show negative 24-hour CVD, indicating aggressive selling. This is particularly notable for ADA, whose OI remains just shy of the recent record high of 2.79 billion tokens, suggesting traders are adding fresh short exposure near record participation levels, not just unwinding old longs.
  • AVAX flips from gainer to loser: Avalanche’s AVAX, one of the top OI gainers earlier this week, is the biggest OI loser of the past 24 hours. Others include LTC, LINK and SOL.
  • Implied volatility stays muted: Options-based implied volatility for bitcoin and ether remains near its recently hit year-to-date lows, suggesting traders aren’t expecting a big move in the short term.
  • Upside bets still surface: In BTC’s case, someone bought a large number of call options at the $65,500 strike, paying $1.07 million in initial premium. This is an ultra-short-term bullish bet; the calls expire Aug. 15.

Token talk

  • XMR is up 3.15% since midnight UTC at around $404, extending its weekly run of more than 11% as the privacy coin continues to outperform the broader market.
  • HYPE is up 1.75% since midnight at $57, continuing a steady grind higher with a 2% gain on the week.
  • FET is up 0.84% since midnight, while NEAR added 0.94%, as a handful of mid-cap altcoins outperform the two largest coins, bitcoin and ether.
  • CRV is giving back some of Wednesday’s surge, falling 8.38% over 24 hours to 25 cents. Still, it remains up more than 22% on the week after breaking above a months-long descending trendline.
  • DeFi token MORPHO was one of the weaker performers, losing 1.51% since midnight.

Source link

Continue Reading

Crypto World

Strategy, Metaplanet unrealized bitcoin losses highlight risk of concentrating on just one token: Crypto Daily

Published

on

Strategy, Metaplanet unrealized bitcoin losses highlight risk of concentrating on just one token: Crypto Daily

Compounding the issue, many DAT firms have consistently favored issuing debt to fund purchases of BTC. That strategy raises the question of how different they are from governments that borrow heavily to fund investments that fail to generate adequate returns. Both, ultimately, lead to high indebtedness relative to income. As we have noted before, bitcoin lacks inherent yield, return or cash flow.

For now, however, the market doesn’t appear to be worried about these dynamics. BTC continues to trade between $62,000 and $66,000, as it has for weeks, with today’s price action largely below $64,000.

Some analysts say they remain optimistic that the bear market has run its course, pointing to a price range that corresponds with the previous bull-cycle high.

“The peaks of the 2021 bull market were close to these levels,” Alex Kuptsikevich, the chief analyst at FxPro, said in an email. “Three years ago, Bitcoin’s decline generally halted at $20K, which was close to the peak of the previous bull market at the end of 2017. This supports our view that the decline may have run its course, with bearish momentum fading as Bitcoin approaches the 200-week moving average.”

Advertisement

Other analysts have turned their focus to August’s Jackson Hole symposium of central banks and economic data for trading cues. Stay alert!

Source link

Continue Reading

Crypto World

Figure Loan Marketplace Volume Reaches $4.3B in Q2

Published

on

Figure Loan Marketplace Volume Reaches $4.3B in Q2

Figure Technology Solutions reported $4.3 billion in consumer loan marketplace volume for the second quarter, up 132% from a year earlier, as its quarterly profit nearly tripled. 

On Thursday, Figure said net income rose 192% year over year to $87 million, from about $30 million. Net revenue more than doubled to $226 million, while its net income margin increased 10.5 percentage points to 38.8%. 

Figure’s marketplace volume includes home equity lines of credit, debt-service coverage ratio loans and personal loans processed through its loan origination system, along with third-party loans traded on Figure Connect, which accounted for $2.8 billion, or 65%, of the quarterly total. 

Volume on the marketplace, which Figure launched in June 2024, increased 262% from the same period last year. The company also added 102 loan-origination partners during the quarter, bringing its total to 489. 

Advertisement

CEO Michael Tannenbaum said weekly loan applications surpassed $1 billion in July. Figure expects consumer loan marketplace volume of between $4.8 billion and $5.2 billion in the third quarter. 

Bernstein analysts predicted in May that Figure would post record second-quarter volume, citing live blockchain data that they said could increasingly allow investors to track the company’s lending activity in real time. 

Related: Tokenized RWA market grows 420% since 2025 on regulatory clarity, access

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently.

Source link

Advertisement
Continue Reading

Crypto World

The Rise of Telehealth 'Pill Mills'

Published

on

The Rise of Telehealth 'Pill Mills'
—Photo-Illustration by TIME (Source Image: irynakhabliuk via Canva)

The elderly patient’s blood pressure had been dropping for weeks, and Chad Wittekind, his primary care provider, couldn’t figure out what was wrong. He had upped the dosage of one medication and added another, but couldn’t manage to regulate it. 

The patient hadn’t reported taking any other new medications or supplements and hadn’t made any major recent lifestyle changes. So what could be causing the blood pressure irregularity? 

It took a lot of questions and appointments to find the culprit: a drug he’d gotten through a telehealth website.

Like many other patients Wittekind has seen recently, this one had circumvented his primary care provider to get a drug over the Internet—in this case, an erectile-dysfunction medication. He’d gone to a website he came across online, filled out a form that a virtual health care provider quickly reviewed, and was sent the medication through the mail, but had been too embarrassed to tell Wittekind about the new addition to his regimen. 

You might not think that Wittekind, a Columbus, Ohio-based provider who works in geriatrics, would be seeing many patients turn to the Internet to get drugs for conditions like erectile dysfunction, overweight, menopause, and depression. But the accessibility of sites like these and the ease of getting meds from them have made them an increasingly popular choice for Americans of all ages and incomes.

Advertisement

Here’s how it works: often after viewing an ad on social media, people click on little-known websites promising a fast and easy way to get medication for a specific condition. These sites accept credit cards, don’t take insurance, and don’t typically make you have a call with a doctor. Instead, you fill out a quick form about your medical history and current medications, and a medical provider you’ll never meet (and will probably never talk to) reviews the information within minutes to hours. If you qualify, they’ll write you a prescription—often a recurring one—and connect you to a pharmacy that ships the drug directly to your home.

Wittekind and other providers see this as a problem. They’re used to patients coming to them asking for some drug they’ve seen advertised on TV, but the fact that patients can now get these drugs elsewhere, without much screening, is worrying. Wittekind has had a patient receive ketamine tablets through a telehealth website, and another got a GLP-1 drug for weight-loss even though they had a BMI of 18.7, meaning they should have been too thin to qualify per U.S. Food and Drug Administration (FDA) guidelines. Sometimes, patients will have side effects from medications, but when they follow up with the virtual doctor who prescribed them, they don’t get a helpful response. 

Sites like these fall under the large umbrella of telehealth, which has unquestionably improved access to medical care, getting services to people who may not be able to easily or quickly find a doctor. It’s also made people much more comfortable seeking treatment for conditions that they might be embarrassed to bring up with their regular doctor, such as erectile dysfunction or hair loss. But telehealth has changed a lot since it started, when it usually referred to a video call with your doctor. Now, it includes hundreds of websites and the pharmacies they partner with—many of which are under-regulated. 

“There’s no accountability, no follow-up if they do have a problem. Trying to get back with their provider is impossible, and then it becomes my problem,” Wittekind says. “There’s no oversight with most of these places. Yes, you’re improving access, but at what cost?”

Advertisement

Why telehealth sites are exploding

Elliot Tabibian started his first telehealth site when he was just 18 years old. You don’t need to be a doctor to do so; all you have to do is figure out a condition that people are seeking treatment for and market your website. Outside companies have popped up to help with the infrastructure side—connecting patients with doctors and pharmacies, for example, and ensuring that the website complies with various state and federal laws. 

Tabibian says he got into telehealth after hearing about a friend who paid a website $200, had a 30-second doctor’s appointment by phone, and got a medical marijuana card. “I thought, ‘that seems pretty profitable, I should get in there,’ says Tabibian, who is now 22.

His first site prescribed medical marijuana; he also tried out sites that sold erectile dysfunction medicines and ones that allowed people to get doctor’s notes stating that they needed service animals. (He shut these sites down after competition got too tight, he says.) He now operates two telehealth sites, one of which helps people get medical exemptions so that they can tint their car windows. “Tired of Cops Taking Your Tint? See if you Qualify for a Medical Tint Exemption in Less than 10 Minutes!” the site reads. It claims to give customers a full refund if they do not get approved for an exemption. 

Tabibian’s is one of hundreds, if not thousands, of telehealth sites that have proliferated in recent years. Though some of the first direct-to-consumer telehealth sites started operating before the pandemic, consumers really started embracing telehealth during it, when many insurers loosened restrictions to ensure more patients had access to care. This allowed medical care to be delivered at home to people who might not be able to travel to receive it elsewhere, expanding access. But what was meant to be a temporary measure became permanent as people grew accustomed to the convenience.

Advertisement

As more people sought out telehealth, entrepreneurs like Tabibian stepped in. They were enabled by companies forming networks of doctors that telehealth companies could contract with to provide services to patients, says Rebecca Gwilt, managing partner of Elevare Law, which consults with digital health care companies.  An entrepreneur only has to create a website and market its services to get a telehealth company off the ground.

These sites became extremely popular once the first GLP-1s debuted in 2021 and immediately went into shortage. People wanted GLP-1s, and many either couldn’t get them or couldn’t afford them. Telehealth entrepreneurs saw an opportunity, Gwilt says. They partnered with a special type of pharmacy, called a compounding pharmacy, that mixed the active ingredients in GLP-1s and sold them for much less than the pharmaceutical companies.

These sites take advantage of several weaknesses in the American medical system. It is expensive and inconvenient to go to the doctor, and patients often need to wait more than a month for an appointment. Insurance is also dismal to deal with, and deductibles and pre-approvals can make getting medications a costly headache.  

Those issues “created a gap that the compounding pharmacies and telehealth facilities were able to step into,” says Dr. Anjali Deshmukh, a pediatrician who is also a professor of health law at Seton Hall University. “They did not create the problem, but they are unquestionably profiting.”

Advertisement

One of the companies that helps entrepreneurs start their own telehealth sites is CareValidate. Co-founder Dr. Jiten Chhabra says he has seen a huge surge of people getting into telehealth—even those “who have no business in telehealth.” CareValidate is growing 20% month over month, he says, buoyed by investors and doctors interested in the idea of cash pay for medical care and specific medications. 

“We’re about to see a telehealth site for everything—it’s going to be very niche,” he says. “It’s going to show up in your social media, and it’s going to be the easiest way to get your hyper-personalized health condition taken care of.”

There are now virtual companies where customers can get diagnoses and prescriptions for things like low testosterone, toenail fungus, and even fear of public speaking. Often, the medicines are prescribed on a recurring basis, creating a long-term demand for the services of the telehealth doctor—and revenue streams for investors. These sites have essentially changed the power dynamic between doctors and patients; now, it’s the patients demanding medications they’ve decided they need from online health care providers, rather than patients asking doctors about what’s best for them.  

Investors see a huge upside because the sites are relatively cheap to launch and because they can turn a profit quickly—either by charging people for visits, selling medications at a markup, or both. Venture capitalists and private equity groups have put millions into telehealth startups, some of which have only a few employees. The size of the U.S. telehealth market was an estimated $28.3 billion in 2025, according to Grand View Research, and is projected to grow to $60.4 billion by 2033. The telehealth boom is concentrated in the U.S., where the high cost of medications and medical care has driven many consumers to telehealth sites; the market is not as strong in other countries. 

Advertisement

The telehealth space is expected to further explode because of interest in peptides, the injectable compounds that wellness influencers have popularized. (Very few clinical studies prove that peptides are effective, aside from those for GLP-1s, one example of  a peptide.) In a two-day July hearing, a FDA committee recommended that the agency allow specialty pharmacies to dispense six peptides; if approval is finalized, many patients are expected to get their prescriptions from telehealth sites. 

Telehealth can be appealing to doctors who are burned out from long hours and negotiating with insurance companies. With telehealth, they can work from home and often avoid insurance altogether.

“The economics are good, the lifestyle is good,” says Chhabra.

The problems with this type of telehealth

The downsides of this direct-to-patient model are starting to become evident. Patients who claim they were prescribed medicines after a cursory online evaluation are filing lawsuits about unanticipated side effects. Several lawsuits allege problems with telehealth companies prescribing at-home ketamine, Adderall, and hair-loss drugs.

Advertisement

In a few cases, patients have died after receiving what their families allege were inadequate telehealth services. Some lawsuits are also accusing telehealth sites of pressuring doctors to act in ways that maximize profit, rather than patient health.

Research suggests that the level of care provided by some of these sites is sometimes poor. In one July 2026 study published in JAMA, a researcher attempted to obtain prescriptions from 49 telehealth websites and found that there was “limited clinician engagement” and that the sites sometimes issued prescriptions, often in as little as five minutes, despite patients not uploading required photos or following other rules of the sites. In some cases, the same clinician provided several different prescriptions for the same patient across multiple sites.

“What we found is really there’s not any sort of true engagement with a clinician,” says Dr. Reshma Ramachandran, a Yale professor and clinician and one of the authors of the study.  “The motivation from these websites is just to prescribe and not necessarily provide health care in the sense of someone actually conveying to that patient the risks and benefits we need to be considering.”  

Because so many sites compete to attract customers, experts say that some doctors are unlikely to turn down requests. Doctors sometimes have quotas of prescriptions they need to meet from the sites or get bonuses for meeting certain goals, says Ramachandran, who has friends who work for telehealth sites. A recent Senate investigation into a handful of telehealth sites found that 85%-100% of patients who interacted with a provider received prescriptions. 

Advertisement

Many patients report that there’s little follow-up from the sites or the doctors they employ, making it difficult for people to know what to do if they develop side effects. Ramachandran, who works at a federally qualified health center for low-income patients, says she has patients coming in who turned to telehealth because insurance got too expensive and were seeking medication, got confused about the dosage they received, and had bad side effects from the medications they took. 

“I think we’re undermining trust in the physician-patient relationship,” says Erin Fuse Brown, a professor of health services, policy and practice at the Brown University School of Public Health. She argues that telehealth sites are similar to “pill mills,” where the prescribers generate prescriptions if there is any conceivable reason to do so. “If you can just go to a website and get the drug you’re seeking after a cursory asynchronous questionnaire, it commercializes medicine in a way that’s a little bit dangerous.” 

Few laws exist to regulate these sites, which have the ability to claim to just be platforms connecting patients and providers. 

“There’s so much money to be made, and so many recent business school graduates running a start-up to get to the next big thing, that this aspect of telemedicine is getting way ahead of regulation, the law, and ethics,” says Arthur Caplan, a professor of bioethics at the NYU Grossman School of Medicine. “It’s like a gold rush.”

Advertisement

Ramachandran says that while telehealth sites may have started as efforts to increase access to care, many have since incorporated incentives for doctors who get patients to try additional medications or take specific costly tests. Her study found that some sites didn’t disclose that the GLP-1s they sold were compounded and made unsubstantiated efficacy claims. 

“There are definitely digital health companies out there that you get concerned are worried about revenue rather than patient care,” says Dr. Suneer Chander, a co-founder of Air Physician Academy, which works to educate doctors about how to ethically enter telehealth. “That’s the sort of stuff we want doctors to understand before they get into digital health so that they can lead the industry, rather than be told what to do.” 

Tabibian, for instance, says one of the doctors who works for his company has done 300 asynchronous visits a day, reviewing patients’ requests for medication. The doctor gets paid $20 per review and has made as much as $6,000 a day. 

Asked if he was worried that 300 prescriptions per day was too many, Tabibian says that it’s up to the doctors to do their due diligence on what’s right for the patients. The way his company is set up, he says, he has no say in any medical decisions. “I’m a technology company. My job is just to connect the patient and physician,” he says. “Anything medical that goes on between the patient and the doctor is 100% the doctor’s responsibility.” 

Advertisement

He does see other sites bend the rules, he says—prescribing testosterone for men whose levels don’t medically support a prescription, for instance. He got ketamine prescribed for himself online because he was interested in starting a ketamine site, and says that he only took half of what the doctor ordered and was so high he couldn’t get out of bed. “That’s just a huge liability,” he says.

Succeeding at telehealth is really about being good at marketing, he says, and people—especially young people—who know how to promote sites through social media can cash in. “It’s really been smooth sailing,” he says. “From what I’ve seen, there’s little to no enforcement in the field.”

Murky regulations 

Few regulations guide what doctors can and can’t do via telehealth. Doctors, for instance, must meet what’s called the “standard of care,” meaning that they are expected to diagnose and treat the patient in the same way other qualified doctors would. But standard-of-care obligations are enforced by medical societies and professional associations, and few have taken steps to punish doctors for not meeting the standard of care through telehealth, says Caplan, the bioethics professor. 

“I’ve tested the sites, and the longest it took me to get whatever pill was about 35 seconds,” he says. “There doesn’t seem to be a thorough medical exam happening.” 

Advertisement

Instead, he says, doctors are prescribing medicine like antidepressants without talking to people to figure out why they might be depressed, or prescribing medications with serious side effects without much warning.  Litigation often only comes after something bad has happened, like a death or other adverse event. 

“I do worry about the fracturing of the medical system more broadly,” says Deshmukh, the Seton Hall professor. “I think having a relationship with a physician who understands you and knows your medical history and can make these decisions together is important.”

State medical boards could step in and discipline doctors who are providing substandard care through telehealth. But “the investigation capacity is really, really limited, and often they just don’t have the resources,” says Ramachandran, the Yale physician and professor. 

There are not many existing federal laws that could effectively regulate telehealth, says Fuse Brown, the professor from Brown. A law called the anti-kickback statute makes it illegal to compensate someone to make referrals for something (for example, medications) paid for by a federal health care program. That would presumably prohibit telehealth sites who make money off of prescriptions from paying doctors to make those prescriptions. But the anti-kickback statute only applies to drugs prescribed through federal programs like Medicare and Medicaid, and many of these sites are cash pay, so the statute wouldn’t apply. 

Advertisement

States could also investigate whether providers who work for these sites are being pressured or incentivized to prescribe more medicines, Fuse Brown, who adds that such pressure could potentially violate state laws.

Even without explicit pressure, telehealth providers know what patients expect of them. Wittekind, the geriatrics provider in Columbus, says he tried out working at a telehealth site after a company pitched him on setting his own hours and making some extra money. But one of his first patients was a man who wanted an oral hair-loss medication that can come with serious side effects, Wittekind says. 

The patient already had hypertension, and Wittekind didn’t think the drug would be a good solution for him, so he turned down the patient’s request. Wittekind realized that his principles probably led to bad reviews for the telehealth site—the patient seemed “perplexed” by the denial—but he didn’t like the idea of prescribing powerful medications without much opportunity for follow-up. He ultimately decided telehealth wasn’t a good fit for him because of that pressure to give the patients what they want. 

It wasn’t worth the extra money,” he says. But to many other clinicians, it is. 

Advertisement

Source link

Continue Reading

Crypto World

Can You Engineer Civic Pride? Dubai Thinks So

Published

on

Can You Engineer Civic Pride? Dubai Thinks So

Do they do this out of fear of being caught and fined? Certainly, rules—and strict consequences for breaking them—are important for creating and maintaining clean spaces. Singapore, my home of two years in the early 2000s, may be the most striking example of the effectiveness of punishment.

But it is too facile to ascribe cleanliness to enforcement alone. Research shows that, over time, people stop littering even when there’s no risk of being caught and punished, because it feels wrong. That was true in Singapore, and it is true in Dubai. “Maybe for the first few weeks or months, you think about the penalties for breaking the law,” remarked Kanchan. “Then you start thinking, ‘This is my town, it’s a pretty clean town… I’d like it to stay that way.”

Dubai and a question of civility

Dubai takes its ranking in global indices very seriously, since the quality of life it offers is a major draw for investors, immigrants and tourists as well as an instrument of its soft power. So you won’t be surprised to learn that municipal authorities are testing AI cameras to supervise how people treat public space. Those found to be littering can expect stiff fines. But in addition to the stick, the emirate is also investing in carrots. Last fall, it launched the Dubai Civility Committee, with an ambitious mandate to “promote positive behaviors” among residents. “No matter how good your enforcement mechanisms are, there’s always a chance of a window breaking somewhere,” said Saeed al Nazari, secretary general of the committee. “We want the whole community to be involved in prevention—and, when necessary, in repair.”

Advertisement

Source link

Continue Reading

Crypto World

Figure (FIGR) gains as revenue doubles, blockchain loan marketplace volumes surge

Published

on

Figure targets Fannie and Freddie in first-lien push, citing 91% cost cut

Figure Technology Solutions (FIGR), the blockchain lending firm co-founded by former SoFi CEO Mike Cagney, more than doubled its revenue in the second quarter as lending activity surged across its marketplace

The company reported $226 million in net revenue for the quarter ended June 30, up 113% from a year earlier. Net income climbed 192% to $87 million, or 35 cents per diluted share, while adjusted EBITDA more than doubled to $119 million.

Growth was driven by Figure’s Consumer Loan Marketplace, where volume reached $4.3 billion, up 132% from a year ago. Figure Connect, its marketplace connecting loan originators with capital providers, accounted for $2.8 billion, or about 65%, of that total.

FIGR shares rose roughly 5% in premarket trading on Thursday, extending Wednesday’s 10% gain.

Advertisement

Figure is one of the more established publicly traded companies trying to move lending and capital-market activity onto blockchain rails. Its platform connects loan originators with investors, using blockchain infrastructure to support the origination, financing and trading of assets such as home-equity loans.

Source link

Continue Reading

Crypto World

Bitmine’s $257M annualized ETH staking income funds gaps, buybacks

Published

on

Crypto Breaking News

Bitmine Immersion Technologies, described by its latest disclosures as the largest corporate holder of staked Ether, has pushed its staking balance beyond the 5 million ETH mark. In an announcement released Monday, the company reported holdings of 5.81 million staked Ether, projecting roughly $257 million in annualized revenue from staking-related income.

The update arrives as Ether treasury firms are increasingly using staking to generate recurring cash flows—while still confronting the risk that reduced spot prices can erode margins and mark-to-market results. Recent figures underscore the tension: Cointelegraph reported that Ether staking accounted for about 98% of Bitmine’s revenue for the fiscal quarter ending May 31.

Key takeaways

  • Bitmine says it has 5.81 million staked ETH, estimating $257 million in annualized staking revenue.
  • According to Bitfinex analysts cited by Cointelegraph, staking drove ~98% of Bitmine revenue in the quarter ending May 31.
  • Ether’s staking income is often treated as steadier than spot price exposure, but it depends on ETH price, staking yield, and operational constraints.
  • Ether treasury companies face mounting paper losses when ETH spot falls; SharpLink reported $391 million in unrealized crypto losses in Q2 2026.
  • As of current staking-network data, Ether staking shows an APR of 2.61%, with 34%+ of supply staked across 897,064 validators.

Bitmine’s staking jump and what it funds

Bitmine’s Monday announcement is framed around a milestone: it has moved past 5 million ETH in staked tokens. The company tied the scale of its staking position to an estimated $257 million in annualized revenue.

Cointelegraph also cited analysis from Bitfinex exchange showing how concentrated Bitmine’s income has become. For the fiscal quarter ending May 31, staking generated $45.7 million out of $46.5 million in total revenue—about 98%.

“It funds operations and its share buyback program: 19.1 million shares repurchased since July against a $4 billion authorisation, without Bitmine having to sell any Ether.”

That last detail matters for how investors may evaluate treasury strategies. If a company can finance buybacks and operating needs without liquidating volatile crypto holdings, it may reduce the need to sell during unfavorable price regimes—at least in principle.

Advertisement

Why Ether is finding a treasury role—and the limits of staking income

Bitmine’s milestone has reinforced a broader trend: Ether staking is increasingly discussed as a way for corporate balance sheets to earn native yield. Cointelegraph quoted Alvin Kan, chief operating officer at Bitget Wallet, arguing that Ether can function as a yield-bearing treasury asset, while Bitcoin is more commonly framed as an asset held for balance-sheet appreciation.

However, Kan stressed that staking revenue is not risk-free. Ether’s yield can vary and treasury operators must manage multiple layers of exposure beyond “headline APR.”

“The revenue is annualized, depends on ETH price and staking yield, and comes with operational, liquidity, validator and regulatory considerations.”

This distinction is important for market participants comparing corporate crypto strategies. Staking can smooth some income—but it does not eliminate the need for disciplined treasury planning. The income model should be viewed as an enhancement to broader capital management rather than a simple replacement for traditional risk controls.

Even where recurring staking income is valued as a “buffer,” the underlying economics remain sensitive to ETH market conditions. Cointelegraph cited an opinion piece from July 28 on Seeking Alpha by Yiannis Zourmpanos, which argued that annualized staking receipts can be modeled with less direct dependence on spot ETH prices. Still, the approach depends on assumptions about yield persistence and the operational ability to sustain staking over time.

Advertisement

Falling ETH spot prices amplify unrealized losses

While staking can generate recurring income, treasury firms are not insulated from valuation impacts when Ether trades lower. The source notes that Ether’s spot price fell roughly 23% during the second quarter of 2026, a move that pressures margins and increases unrealized losses for entities holding large crypto reserves.

SharpLink, identified as the second-largest Ether treasury company, illustrates the problem. Cointelegraph reported that SharpLink posted a $394 million net loss for Q2 2026, driven largely by $391 million in unrealized crypto losses.

That contrast with Bitmine’s staking-heavy revenue highlights a key asymmetry. A company can generate staking proceeds without selling—yet its financial statements may still reflect spot-driven mark-to-market declines on the underlying holdings. For investors, the practical question becomes whether staking income is sufficient to offset these valuation moves on a reported basis, and how much of the exposure is unrealized versus realized.

How much Ether is staked—and who leads among corporate holders

The staking activity behind Bitmine’s model is supported by broader network participation. According to data from Validatorqueue, Ether staking currently offers an APR of 2.61%. The same dashboard shows that over 34% of the total Ether supply is staked across 897,064 validators.

Advertisement

In corporate terms, the data cited in the source points to a clear leader-follower dynamic. Cointelegraph stated that Bitmine is currently the largest corporate Ether holder at 5.54 million ETH (worth about $9.4 billion at the referenced valuation), while SharpLink ranks second with 863,000 ETH (about $1.46 billion), according to information from the StrategicEthReserve data site.

Taken together, the figures suggest why staking is drawing attention from corporate treasuries: it can be scaled, monitored, and used to generate ongoing returns. But the same scale also magnifies reporting effects when ETH’s market price drops, increasing the importance of underwriting assumptions around yield durability and liquidity management.

Next, investors should watch whether corporate staking earnings remain stable as network conditions and ETH yield dynamics shift, and whether reported losses from spot declines continue to overwhelm staking proceeds—or eventually stabilize as prices and staking economics realign.

Risk & affiliate notice: Crypto assets are volatile and capital is at risk. This article may contain affiliate links. Read full disclosure

Advertisement

Source link

Continue Reading

Crypto World

Tether Finishes First Full Audit, Gets Clean KPMG Opinion

Published

on

Crypto Breaking News

Tether has moved to put a new layer of third-party scrutiny around its finances, completing an independent audit of its annual financial statements. KPMG US issued a clean, or “unqualified,” opinion on Tether’s 2025 accounts, covering the company’s balance sheet, income statement, and cash flows for the year ended Dec. 31, 2025.

In its announcement, Tether said the audited results show reserves exceeding liabilities by $6.814 billion, and it emphasized that the engagement went beyond its long-running quarterly reserve attestations by examining broader financial statements and supporting evidence.

Key takeaways

  • KPMG US issued an unqualified opinion on Tether’s 2025 annual financial statements under US accounting standards.
  • The audit covered assets backing issued tokens and the liabilities those tokens represent, including transactions, systems, and ownership records.
  • Tether reported that reserves exceeded liabilities by $6.814 billion in the audited period.
  • KPMG’s work included physical inspection and counting of Tether’s gold holdings, not just reliance on custodian documentation.

A full annual audit replaces “attestation” level scrutiny

For years, Tether has published quarterly reserve attestations intended to provide visibility into the backing of its stablecoin. The new audit is designed to be broader and more demanding: rather than focusing only on reserve composition at a point in time, KPMG reviewed the company’s full annual financial statements and the underlying materials that support them.

According to Tether, the independent review examined not only the balances reflected on the statements, but also the evidence behind them—such as transaction records, valuations, counterparties, and internal systems used to produce the financial reporting. Tether said the audit subjected the company’s year-end financial position to examination in the same way an external auditor would assess any public-facing US financial report.

Under the audit’s findings, KPMG concluded that Tether’s financial statements fairly present the company’s financial position, results, and cash flows “in all material respects,” using US accounting standards—an outcome typically read by markets as a strong baseline for reporting reliability.

Advertisement

What the audit found: reserves over liabilities

Tether’s announcement ties the audit’s headline takeaway to a simple balance-sheet relationship: it reported that audited reserves exceeded audited liabilities by $6.814 billion for the year ended Dec. 31, 2025.

While the specific arithmetic is confined to the audited statements themselves, the practical implication is straightforward for readers following stablecoin solvency narratives: an independent auditor reviewed the accounts and did not issue qualifications that would suggest material misstatement under the applicable framework.

Tether also indicated that the audit covered key components investors often track in stablecoins—namely, how the assets held by the issuer relate to the liabilities created by issued tokens.

Physical verification of gold highlights a key diligence point

One notable detail Tether highlighted is that KPMG physically inspected and counted Tether’s gold holdings as part of the audit. Tether said the verification process involved checking each bar, rather than depending solely on records from custodians.

Advertisement

In the context of stablecoins that hold commodity exposures, this kind of verification matters because it reduces reliance on third-party documentation in isolation. Instead, it introduces an additional layer of direct confirmation tied to the asset itself—particularly relevant when discussions about reserve transparency can otherwise focus on what is visible on paper versus what is independently verifiable.

Why the audit matters for stablecoin users and markets

Since launching USDt (USDT) in 2014, Tether has grown into one of crypto’s dominant financial rails. The stablecoin remains the core of the company’s business, and its market size is frequently cited as a key driver of stablecoin liquidity across exchanges and on-chain markets.

The scale of Tether’s footprint is reinforced by broader market metrics. According to DefiLlama data cited in the article, USDT’s market capitalization is roughly $183 billion, representing about 61% of the total stablecoin market of roughly $301 billion. The same comparison puts Circle’s USDC at roughly $72 billion in market capitalization.

In that environment, an annual independent audit can be more than a compliance step—it can affect how counterparties, institutional allocators, and auditors approach risk management. Quarterly attestations help, but a full annual audit is typically seen as a higher standard because it focuses on financial statements holistically rather than only on reserve snapshots.

Advertisement

Tether has also continued to expand its broader business beyond plain stablecoins. In 2025, Tether reported more than $10 billion in net profit, and it has disclosed additional activity tied to tokenized gold products (Tether Gold, XAUt) and other investments. These moves matter because they increase the range of claims investors might want to understand through consistent, auditable reporting.

At the same time, Tether’s executives have not signaled a near-term plan to list the company publicly. The article notes that in June 2025, CEO Paolo Ardoino posted on X, “No need to go public,” in response to speculation about a potential IPO. For markets, that context can influence expectations: if the issuer doesn’t pursue public-market scrutiny, an annual audited statement can function as an alternative transparency anchor.

What to watch next

With KPMG’s unqualified opinion now attached to Tether’s 2025 annual accounts, the next question for investors and stablecoin users is whether future years continue to follow the same audited approach and how Tether’s audited reserve picture evolves as its product lineup grows. In the meantime, the combination of physical asset verification and a full-statement audit offers a clearer baseline for assessing the issuer’s reported financial health.

Risk & affiliate notice: Crypto assets are volatile and capital is at risk. This article may contain affiliate links. Read full disclosure

Advertisement

Source link

Continue Reading

Crypto World

CFTC to Join SEC in Exploring Crypto Regulations without CLARITY Bill

Published

on

CFTC to Join SEC in Exploring Crypto Regulations without CLARITY Bill

Cointelegraph is committed to providing independent, high-quality journalism across the crypto, blockchain, AI, and fintech industries.

All news, reviews, and analyses are produced with full journalistic independence and integrity. For more details on our standards and processes, please read our Editorial Policy.

Source link

Advertisement
Continue Reading

Crypto World

Bitcoin Stays Near $64K as US PPI Softens and Stocks Rise

Published

on

Crypto Breaking News

Bitcoin steadied after a dip toward weekly lows, with the latest catalyst coming from cooling US inflation data. On Thursday, BTC moved modestly higher as July’s Producer Price Index (PPI) showed a small decline in the annual rate and left month-on-month inflation unchanged, easing pressure on rate-hike expectations.

Still, traders are watching key downside levels closely. On-chain and liquidation analytics indicate that a move toward $61,000 could trigger concentrated long-position liquidations, potentially accelerating selling if that support breaks.

Key takeaways

  • July US PPI came in softer than expected on a year-over-year basis, supporting a risk-on tone in traditional markets.
  • Federal Reserve officials remain split on the rate path, but Cleveland Fed president Beth Hammack delivered a cautious message on inflation progress.
  • Bitcoin’s near-term price action appears range-bound, leaving liquidation zones at the edges of the range more influential.
  • Glassnode cofounder Rafael Schultze-Kraft highlighted $61,000 as a potential flashpoint due to built-up long liquidation risk.

July PPI cools, supports US stocks—and Bitcoin

According to TradingView data, BTC/USD was up roughly 0.5% on the day near $63,900, with volatility relatively muted at the time. The broader tailwind came from July’s US Producer Price Index print published by the US Bureau of Labor Statistics (BLS).

Per the BLS, July’s PPI was unchanged month-on-month at 0.2%, while the year-over-year increase slowed to 4.7% compared with a 4.9% expectation. The BLS attributed the monthly flat reading to offsetting components: a 0.2% rise in final demand services and a 2.2% increase in final demand construction, countered by a 0.7% decrease in final demand goods.

The BLS also noted that falling gasoline and energy prices provided the largest source of relief. Econoday analysts similarly pointed to the flat overall outcome in their commentary on the report.

Advertisement

As the PPI release hit markets, US equities rose at the open. At the time of writing, the S&P 500 and the Nasdaq Composite were up 0.87% and 0.94%, respectively, reflecting renewed optimism that inflation pressures may be easing enough to keep the Federal Reserve on hold.

For crypto investors, the immediate significance is clear: when inflation prints reduce the probability of further tightening, it can improve sentiment across risk assets, including Bitcoin—even if crypto-specific drivers remain secondary in the short run.

Rate-hike bets shift, but the Fed’s tone stays careful

Rate expectations moved in tandem with the data. CME Group’s FedWatch Tool showed 65.6% odds that the Federal Open Market Committee (FOMC) would hold interest rates at the current 3.50% to 3.75% level at its September meeting. The update followed Wednesday’s July Consumer Price Index (CPI) release, which matched expectations and had already supported the “pause” narrative.

However, inflation data may not be enough on its own to settle the Fed debate. The Cleveland Federal Reserve Bank’s president, Beth Hammack, questioned whether recent cooling prints would reliably bring inflation down to the Fed’s 2% goal—and whether the time required would be acceptable. In remarks delivered at an event in Kettering, Ohio, Hammack suggested policymakers may still need continued improvement rather than assuming that favorable prints guarantee a quicker path to target.

Advertisement

Bloomberg reported Hammack’s remarks with the framing that even if the central bank reaches its goal, it could take another three to four years, raising the question of whether that timeline is “OK” for the committee’s outlook.

Notably, Hammack was one of three Fed officials who supported a 0.25% rate hike in July, underscoring that a cautious stance remains present even as incoming inflation data moderates.

Traders eye liquidation pressure near $61,000

Even with the macro tailwind, Bitcoin’s price action has been relatively contained. That makes positioning and liquidation levels more important when BTC approaches range extremes.

Glassnode cofounder Rafael Schultze-Kraft pointed to $61,000 as the next potential trouble spot. In an earlier Tuesday post on X, he wrote that long liquidation risk has built up around $61K over the past few weeks, and that if price reaches that area, forced selling could add momentum to the downside.

Advertisement

In other words, rather than relying purely on technical support as a “line in the sand,” traders may also be considering how derivatives mechanics could amplify any break. When liquidation clusters are concentrated, the market can transition quickly from a slow bleed to a sharp drop—especially if liquidity thins.

This focus on $61,000 also fits with earlier market commentary from Cointelegraph, which reported that $63,000 had started forming a key level after repeated retests increased the odds of a support failure if buyers failed to defend it.

From a trading perspective, the key implication is not that $61,000 is guaranteed to break—rather, it highlights where downside acceleration risk is most pronounced if momentum turns bearish. For spot holders and derivatives traders, that distinction matters: the level is important partly because of how it could trigger broader, mechanical selling pressure.

As of this writing, Bitcoin is still trading off the bounce from weekly weakness, but with macro expectations and Fed messaging still in flux, attention is likely to keep oscillating between inflation-driven sentiment and crypto-specific positioning.

Advertisement

Looking ahead, traders should monitor whether further inflation-related surprises continue to soften rate expectations—and whether BTC can hold key intraday levels without drawing price toward the liquidation pocket around $61,000. The next decisive move may come less from a single headline and more from how markets price the Fed’s timeline after each new data release.

Risk & affiliate notice: Crypto assets are volatile and capital is at risk. This article may contain affiliate links. Read full disclosure

Source link

Advertisement
Continue Reading

Trending

Copyright © 2025